Some studies have found that the majority (80%) of breast cancer cases expressing the BRCA1 hereditary mutated form can be classified as triple-negative breast cancers (TNBC) and/or basal-like breast cancers (BLBC) [60], of which TNBCs represent 15% to 20%. The gene discussed is BRCA1; the disease is breast cancer.